The Effect of a Short Course of Tocolytic Indomethacin on Urinary Biomarkers in Premature Infants

Abstract

Objective The aim of this study was to determine the effects of a 2-day prenatal course of indomethacin on the premature kidney as reflected by serum creatinine and urinary biomarkers.

Study Design Urine of infants ≤32 weeks was collected for the first 14 days and analyzed for cystatin C, neutrophil gelatinase-associated lipocalin, osteopontin, β2 microglobulin, epidermal growth factor, uromodulin, and microalbumin. Bivariate analysis compared serum creatinine and biomarkers of exposed (INDO) and unexposed (CONT) subjects.

Results Fifty-seven infants (35 CONT and 22 INDO) were studied. The cohorts were similar in gestational age, birthweight, race, gender, nephrotoxic medication exposure, and Apgar's scores. CONT had more dopamine exposure and included more pre-eclamptic mothers (p = 0.005). No difference in creatinine-based acute kidney injury or the log transformed mean, maximum, and minimum values of urinary biomarkers was detected.

Conclusion Our findings suggest that a short course of tocolytic indomethacin does not result in neonatal acute kidney injury.

Key Points

• A short prenatal course of indomethacin does not result in neonatal acute kidney injury (AKI).

• Urinary EGF might have a promising role as a more sensitive biomarker for early detection of AKI in premature infants.

Keywords

acute kidney injury - prematurity - biomarkers - indomethacin

Publication History

Received: 03 August 2020

Accepted: 05 January 2021

Article published online:
16 February 2021

• References

• 1 Jacob JA. US infant mortality rate declines but still exceeds other developed countries. JAMA 2016; 315 (05) 451-452
• 2 Askenazi DJ, Griffin R, McGwin G, Carlo W, Ambalavanan N. Acute kidney injury is independently associated with mortality in very low birthweight infants: a matched case-control analysis. Pediatr Nephrol 2009; 24 (05) 991-997
• 3 Selewski DT, Charlton JR, Jetton JG. et al. Neonatal acute kidney injury. Pediatrics 2015; 136 (02) e463-e473
• 4 Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006; 29 (05) 397-419
• 5 Butler-O'Hara M, D'Angio CT. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. J Perinatol 2002; 22 (07) 541-546
• 6 van den Anker JN, Hop WC, de Groot R. et al. Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr Res 1994; 36 (05) 578-581
• 7 Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?. Pediatr Nephrol 2009; 24 (02) 265-274
• 8 Askenazi DJ, Koralkar R, Levitan EB. et al. Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants. Pediatr Res 2011; 70 (03) 302-306
• 9 Huynh TK, Bateman DA, Parravicini E. et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res 2009; 66 (05) 528-532
• 10 Hanna M, Brophy PD, Giannone PJ, Joshi MS, Bauer JA, RamachandraRao S. Early urinary biomarkers of acute kidney injury in preterm infants. Pediatr Res 2016; 80 (02) 218-223
• 11 Askenazi DJ, Montesanti A, Hundley H. et al. Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants. J Pediatr 2011; 159 (06) 907-12.e1
• 12 Askenazi DJ, Koralkar R, Patil N, Halloran B, Ambalavanan N, Griffin R. Acute kidney injury urine biomarkers in very low-birth-weight infants. Clin J Am Soc Nephrol 2016; 11 (09) 1527-1535
• 13 Elmas AT, Karadag A, Tabel Y, Ozdemir R, Otlu G. Analysis of urine biomarkers for early determination of acute kidney injury in non-septic and non-asphyxiated critically ill preterm neonates. J Matern Fetal Neonatal Med 2017; 30(3): 302-308
• 14 Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993; 329 (22) 1602-1607
• 15 vd Heijden AJ, Provoost AP, Nauta J. et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res 1988; 24 (05) 644-648
• 16 Chen L, Liu W. Effect of asphyxia on urinary epidermal growth factor levels in newborns. J Tongji Med Univ 1997; 17 (03) 144-146
• 17 Bernstein J, Werner AL, Verani R. Nonsteroidal anti-inflammatory drug fetal nephrotoxicity. Pediatr Dev Pathol 1998; 1 (02) 153-156
• 18 Novy MJ. Effects of indomethacin on labor, fetal oxygenation, and fetal development in rhesus monkeys. Adv Prostaglandin Thromboxane Res 1978; 4: 285-300
• 19 Blinder JJ, Goldstein SL, Lee VV. et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 2012; 143 (02) 368-374
• 20 Sarafidis K, Tsepkentzi E, Agakidou E. et al. Serum and urine acute kidney injury biomarkers in asphyxiated neonates. Pediatr Nephrol 2012; 27 (09) 1575-1582
• 21 Askenazi DJ, Koralkar R, Hundley HE. et al. Urine biomarkers predict acute kidney injury in newborns. J Pediatr 2012; 161 (02) 270-5.e1
• 22 Tabel Y, Elmas A, Ipek S, Karadag A, Elmas O, Ozyalin F. Urinary neutrophil gelatinase-associated lipocalin as an early biomarker for prediction of acute kidney injury in preterm infants. Am J Perinatol 2014; 31 (02) 167-174
• 23 Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S, Askenazi D. Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res 2011; 69 (04) 354-358